{"id":458443,"date":"2021-03-16T07:48:03","date_gmt":"2021-03-16T11:48:03","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=458443"},"modified":"2021-03-16T07:48:03","modified_gmt":"2021-03-16T11:48:03","slug":"nephros-to-present-at-the-q1-virtual-investor-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/","title":{"rendered":"Nephros to Present at the Q1 Virtual Investor Summit"},"content":{"rendered":"
\n

SOUTH ORANGE, N.J., March 16, 2021 (GLOBE NEWSWIRE) — via InvestorWire \u2013 Nephros<\/a>, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy Astor, Chief Executive Officer, has been invited to present at the Q1 Virtual Investor Summit. The conference will take place on March 23-25, 2021, and includes a Nephros company presentation and Q&A at 2:30 p.m. ET on March 23.<\/p>\n

To register to attend the live presentation click the following link:<\/p>\n

\n https:\/\/zoom.us\/webinar\/register\/WN_rBYVMLR8RP6-JbQsQa1qOQ<\/a>\n <\/p>\n

To request a complimentary investor registration and 1-to-1 meeting with Nephros, please visit the conference website at www.investorsummitgroup.com<\/a>.<\/p>\n

\n About Nephros<\/strong>\n <\/p>\n

Nephros is a leading water technology company in medical and commercial water purification and pathogen detection, headquartered in the USA. Our diverse team of passionate employees are dedicated to advancing point-of-use water safety through education, product solutions, and emergency outbreak response management.<\/p>\n

For more information about Nephros, please visit www.nephros.com<\/a>.<\/p>\n

\n About The Investor Summit<\/strong>\n <\/p>\n

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting small-cap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors.\u00a0<\/p>\n

\n Conference Contact:\u00a0<\/strong>
\n
Brittney Blocker at brittney@investorsummitgroup.com<\/a><\/p>\n

\n Investor Relations Contact:<\/strong>
\n
Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com<\/a>
www.pcgadvisory.com<\/a><\/p>\n

\n Company Contact:<\/strong>
\n
Andy Astor, President and CEO
Nephros, Inc.
(201) 345-0824
andy@nephros.com<\/a>
www.nephros.com<\/a><\/p>\n

\n Wire Service Contact<\/strong>
\n
InvestorWire (IW)
Los Angeles, California
www.InvestorWire.com<\/a>
212.418.1217 Office
Editor@InvestorWire.com<\/a><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SOUTH ORANGE, N.J., March 16, 2021 (GLOBE NEWSWIRE) — via InvestorWire \u2013 Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy Astor, Chief Executive Officer, has been invited to present at the Q1 Virtual Investor Summit. The conference will take place on March 23-25, 2021, and includes a Nephros company presentation and Q&A at 2:30 p.m. ET on March 23. To register to attend the live presentation click the following link: https:\/\/zoom.us\/webinar\/register\/WN_rBYVMLR8RP6-JbQsQa1qOQ To request a complimentary investor registration and 1-to-1 meeting with Nephros, please visit the conference website at www.investorsummitgroup.com. About Nephros Nephros is a leading water technology company in medical and commercial water … <\/p>\n

Continue reading “Nephros to Present at the Q1 Virtual Investor Summit”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-458443","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNephros to Present at the Q1 Virtual Investor Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nephros to Present at the Q1 Virtual Investor Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH ORANGE, N.J., March 16, 2021 (GLOBE NEWSWIRE) — via InvestorWire \u2013 Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy Astor, Chief Executive Officer, has been invited to present at the Q1 Virtual Investor Summit. The conference will take place on March 23-25, 2021, and includes a Nephros company presentation and Q&A at 2:30 p.m. ET on March 23. To register to attend the live presentation click the following link: https:\/\/zoom.us\/webinar\/register\/WN_rBYVMLR8RP6-JbQsQa1qOQ To request a complimentary investor registration and 1-to-1 meeting with Nephros, please visit the conference website at www.investorsummitgroup.com. About Nephros Nephros is a leading water technology company in medical and commercial water … Continue reading "Nephros to Present at the Q1 Virtual Investor Summit"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-16T11:48:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDcyNiM0MDY2MDg5IzUwMDA3ODU4Mw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nephros-to-present-at-the-q1-virtual-investor-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nephros-to-present-at-the-q1-virtual-investor-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nephros to Present at the Q1 Virtual Investor Summit\",\"datePublished\":\"2021-03-16T11:48:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nephros-to-present-at-the-q1-virtual-investor-summit\\\/\"},\"wordCount\":272,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nephros-to-present-at-the-q1-virtual-investor-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDcyNiM0MDY2MDg5IzUwMDA3ODU4Mw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nephros-to-present-at-the-q1-virtual-investor-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nephros-to-present-at-the-q1-virtual-investor-summit\\\/\",\"name\":\"Nephros to Present at the Q1 Virtual Investor Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nephros-to-present-at-the-q1-virtual-investor-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nephros-to-present-at-the-q1-virtual-investor-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDcyNiM0MDY2MDg5IzUwMDA3ODU4Mw==\",\"datePublished\":\"2021-03-16T11:48:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nephros-to-present-at-the-q1-virtual-investor-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nephros-to-present-at-the-q1-virtual-investor-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nephros-to-present-at-the-q1-virtual-investor-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDcyNiM0MDY2MDg5IzUwMDA3ODU4Mw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDcyNiM0MDY2MDg5IzUwMDA3ODU4Mw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nephros-to-present-at-the-q1-virtual-investor-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nephros to Present at the Q1 Virtual Investor Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nephros to Present at the Q1 Virtual Investor Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/","og_locale":"en_US","og_type":"article","og_title":"Nephros to Present at the Q1 Virtual Investor Summit - Market Newsdesk","og_description":"SOUTH ORANGE, N.J., March 16, 2021 (GLOBE NEWSWIRE) — via InvestorWire \u2013 Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy Astor, Chief Executive Officer, has been invited to present at the Q1 Virtual Investor Summit. The conference will take place on March 23-25, 2021, and includes a Nephros company presentation and Q&A at 2:30 p.m. ET on March 23. To register to attend the live presentation click the following link: https:\/\/zoom.us\/webinar\/register\/WN_rBYVMLR8RP6-JbQsQa1qOQ To request a complimentary investor registration and 1-to-1 meeting with Nephros, please visit the conference website at www.investorsummitgroup.com. About Nephros Nephros is a leading water technology company in medical and commercial water … Continue reading \"Nephros to Present at the Q1 Virtual Investor Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-16T11:48:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDcyNiM0MDY2MDg5IzUwMDA3ODU4Mw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nephros to Present at the Q1 Virtual Investor Summit","datePublished":"2021-03-16T11:48:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/"},"wordCount":272,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDcyNiM0MDY2MDg5IzUwMDA3ODU4Mw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/","name":"Nephros to Present at the Q1 Virtual Investor Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDcyNiM0MDY2MDg5IzUwMDA3ODU4Mw==","datePublished":"2021-03-16T11:48:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDcyNiM0MDY2MDg5IzUwMDA3ODU4Mw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDcyNiM0MDY2MDg5IzUwMDA3ODU4Mw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nephros-to-present-at-the-q1-virtual-investor-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nephros to Present at the Q1 Virtual Investor Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=458443"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/458443\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=458443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=458443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=458443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}